ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Modified World Health Organization classification of cardiovascular disease in pregnancy

Modified World Health Organization classification of cardiovascular disease in pregnancy
Risk classification Cardiac lesions

Class I

No detectable increased risk of maternal mortality and no or minimal increase in maternal morbidity
  • Uncomplicated mild pulmonary stenosis
  • Ventricular septal defect
  • Patent ductus arteriosus
  • Mitral valve prolapse with no more than trivial mitral regurgitation
  • Successfully repaired simple lesions (atrial or ventricular septal defect, patent ductus arteriosus, anomalous pulmonary venous drainage)
  • Isolated ventricular extra-systoles and atrial ectopic beats

Class II

Small increased risk of maternal mortality or moderate increase in morbidity
  • Unoperated atrial or ventricular septal defect
  • Repaired tetralogy of Fallot
  • Most arrhythmias

Class II-III

Some increased risk depending on patient
  • Hypertrophic cardiomyopathy
  • Native or tissue valvular heart disease not considered mWHO I or IV
  • Repaired coarctation
  • Marfan syndrome without aortic dilatation
  • Bicuspid valve with aorta <45 mm
  • Mild ventricular impairment
  • Heart transplantation

Class III

Significantly increased risk of maternal mortality or severe morbidity
  • Mechanical valve
  • Systemic right ventricle
  • Fontan circulation
  • Unrepaired cyanotic heart disease
  • Other complex congenital heart disease
  • Marfan syndrome with aorta 40 to 45 mm
  • Bicuspid aortic valve with aorta 45 to 50 mm

Class IV

Pregnancy is contraindicated
  • Pulmonary hypertension
  • Eisenmenger syndrome
  • Systemic ventricular EF <30%
  • Systemic ventricular dysfunction with NYHA class III-IV
  • Severe mitral stenosis or symptomatic aortic stenosis
  • Marfan syndrome with aorta >45 mm
  • Bicuspid aortic valve with aorta >50 mm
  • Native severe coarctation
  • Prior peripartum cardiomyopathy with any residual impairment of ventricular function
mWHO: modified World Health Organization; EF: ejection fraction; NYHA: New York Heart Association.
From: Meng ML, Arendt KW. Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations. Anesthesiology 2021; 135:164. DOI: 10.1097/ALN.0000000000003833. Copyright © 2021 American Society of Anesthesiologists. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 134079 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟